What is the appropriate dosing for melatonin (melatonin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025 • View editorial policy

From the Guidelines

Melatonin should be dosed between 0.5-5 mg for adults, with a starting dose of 3 mg taken at bedtime, as recommended by the most recent and highest quality study 1. When considering melatonin dosing, it's essential to prioritize the patient's specific needs and conditions.

  • For sleep onset insomnia, lower doses (0.5-1 mg) are often effective, while sleep maintenance issues may require slightly higher doses (2-5 mg).
  • Children generally need lower doses, ranging from 0.5-3 mg based on age and weight.
  • Extended-release formulations are better for maintaining sleep throughout the night, while immediate-release forms help with falling asleep. The American Academy of Sleep Medicine recommends melatonin for the treatment of intrinsic circadian rhythm sleep-wake disorders, including advanced sleep-wake phase disorder, delayed sleep-wake phase disorder, non-24-hour sleep-wake rhythm disorder, and irregular sleep-wake rhythm disorder 2, 3. Melatonin works by binding to receptors in the brain that regulate the sleep-wake cycle, reinforcing your natural circadian rhythm, and is most effective for jet lag, delayed sleep phase syndrome, and certain types of insomnia 1, 4. It's crucial to start with the lowest effective dose to minimize side effects like morning grogginess, headaches, or vivid dreams, and to consult a healthcare provider before using melatonin regularly for more than a few weeks, especially if you take other medications or have underlying health conditions.

From the FDA Drug Label

PRINCIPAL DISPLAY PANEL - Vitamin Bottle Label Safrel Melatonin 3mg Tablets: The FDA drug label does not answer the question.

From the Research

Melatonin Dosing

  • The ideal dose of melatonin for sleep disorders is not clearly defined, with studies using a broad range of doses (0.1-2000 mg) 5.
  • A systematic review and meta-analysis found that higher doses of melatonin (≥10 mg) appear to have a good safety profile, but may increase the risk of adverse events such as drowsiness, headache, and dizziness 6.
  • The timing of melatonin treatment is also important, with evidence suggesting that it is most effective when taken at the right time to synchronize the circadian rhythms 7, 8.
  • The suitable dose ranges and pharmaceutical preparations for melatonin administration are yet to be clearly defined, with more research needed to determine the optimal dosing regimen 9.
  • Melatonin has been shown to be effective in improving sleep quality, duration, and onset, but the evidence is not yet conclusive, and more studies are needed to fully understand its effects 7, 5.

References

Guideline

management of rem sleep behavior disorder: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2023

Guideline

best practice guide for the treatment of rem sleep behavior disorder (rbd).

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

Research

A review of sleep disorders and melatonin.

Neurological research, 2017

Research

Clinical update: melatonin and sleep disorders.

Clinical medicine (London, England), 2008

Research

Melatonin in sleep disorders.

Neurologia, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.